Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

2.

[Combined antimalarial therapy using artemisinin].

Majori G.

Parassitologia. 2004 Jun;46(1-2):85-7. Review. Italian.

PMID:
15305693
3.
4.

Spread and evolution of Plasmodium falciparum drug resistance.

Mita T, Tanabe K, Kita K.

Parasitol Int. 2009 Sep;58(3):201-9. doi: 10.1016/j.parint.2009.04.004. Epub 2009 Apr 23. Review.

PMID:
19393762
5.

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM.

Trends Parasitol. 2001 Dec;17(12):582-8. Review.

PMID:
11756042
6.

[Mechanisms and dynamics of drug resistance in Plasmodium falciparum].

Le Bras J.

Bull Soc Pathol Exot. 1999 Sep-Oct;92(4):236-41. Review. French.

PMID:
10572658
7.

The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.

Le Bras J, Durand R.

Fundam Clin Pharmacol. 2003 Apr;17(2):147-53. Review.

PMID:
12667224
8.

[Artemisinin resistance in Plasmodium falciparum: global status and basic research].

Zhao SM, Wang MY.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2014 Oct;32(5):380-4. Review. Chinese.

PMID:
25726605
9.

Epidemiology of drug-resistant malaria.

Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR.

Lancet Infect Dis. 2002 Apr;2(4):209-18. Review.

PMID:
11937421
10.

Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance.

Wongsrichanalai C, Sibley CH.

Clin Microbiol Infect. 2013 Oct;19(10):908-16. doi: 10.1111/1469-0691.12316. Epub 2013 Sep 3. Review.

11.

Artemisinin-Resistant Plasmodium falciparum Malaria.

Fairhurst RM, Dondorp AM.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.EI10-0013-2016. Review.

12.

How genomics is contributing to the fight against artemisinin-resistant malaria parasites.

Cravo P, Napolitano H, Culleton R.

Acta Trop. 2015 Aug;148:1-7. doi: 10.1016/j.actatropica.2015.04.007. Epub 2015 Apr 21. Review.

PMID:
25910626
13.

Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.

Talisuna AO, Karema C, Ogutu B, Juma E, Logedi J, Nyandigisi A, Mulenga M, Mbacham WF, Roper C, Guerin PJ, D'Alessandro U, Snow RW.

Lancet Infect Dis. 2012 Nov;12(11):888-96. doi: 10.1016/S1473-3099(12)70241-4. Review.

14.

The need for new antimalarial drugs less prone to resistance.

Noedl H.

Curr Pharm Des. 2013;19(2):266-9. Review.

PMID:
22973887
15.

Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance.

von Seidlein L, Dondorp A.

Expert Rev Anti Infect Ther. 2015 Jun;13(6):715-30. doi: 10.1586/14787210.2015.1031744. Epub 2015 Apr 1. Review.

PMID:
25831482
16.

The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.

Woodrow CJ, White NJ.

FEMS Microbiol Rev. 2017 Jan;41(1):34-48. doi: 10.1093/femsre/fuw037. Epub 2016 Sep 8. Review.

17.
18.

Origins and spread of pfdhfr mutant alleles in Plasmodium falciparum.

Mita T.

Acta Trop. 2010 Jun;114(3):166-70. doi: 10.1016/j.actatropica.2009.07.008. Epub 2009 Jul 14. Review.

PMID:
19607799
19.

Chloroquine and artemisinin: six decades of research--what next?

Delhaes L, Benoit-Vical F, Camus D, Capron M, Meunier B.

IDrugs. 2003 Jul;6(7):674-80. Review.

PMID:
12861472
20.

Plasmodium falciparum kelch 13: a potential molecular marker for tackling artemisinin-resistant malaria parasites.

Mita T, Tachibana S, Hashimoto M, Hirai M.

Expert Rev Anti Infect Ther. 2016;14(1):125-35. doi: 10.1586/14787210.2016.1106938. Epub 2015 Nov 4. Review.

PMID:
26535806

Supplemental Content

Support Center